Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 627181, 10 pages
http://dx.doi.org/10.1155/2014/627181
Research Article

Tetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings: Implications for Antioxidant Therapy of Vascular Diseases

1Guangdong Provincial Hospital of Chinese Medicine, No. 111 Dade Road, Guangzhou 510120, China
2Second College of Clinical Medicine, Guangzhou University of Chinese Medicine, No. 12 Jichang Road, Guangzhou 510405, China
3School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, NT, Hong Kong

Received 24 February 2014; Revised 30 July 2014; Accepted 7 August 2014; Published 2 September 2014

Academic Editor: I-Min Liu

Copyright © 2014 Xiaojia Ni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Loscalzo, “Oxidant stress: A key determinant of atherothrombosis,” Biochemical Society Transactions, vol. 31, no. 5, pp. 1059–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mudau, A. Genis, A. Lochner, and H. Strijdom, “Endothelial dysfunction: the early predictor of atherosclerosis,” Cardiovascular Journal of Africa, vol. 23, no. 4, pp. 222–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Frostegård, “Immunity, atherosclerosis and cardiovascular disease,” BMC Medicine, vol. 11, article 117, 2013. View at Publisher · View at Google Scholar
  4. P. Dutta, G. Courties, Y. Wei et al., “Myocardial infarction accelerates atherosclerosis,” Nature, vol. 487, no. 7407, pp. 325–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. B. Goldstein, C. D. Bushnell, R. J. Adams et al., “Guidelines for the primary prevention of stroke: a guideline forhealthcare professionals from the American Heart Association/American StrokeAssociation,” Stroke, vol. 42, no. 2, pp. 517–584, 2011. View at Google Scholar
  6. P. O. Vandvik, A. M. Lincoff, J. M. Gore et al., “Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines,” Chest, vol. 141, no. 2, supplement, pp. e637S–e668S, 2012. View at Publisher · View at Google Scholar
  7. A. R. Weseler and A. Bast, “Oxidative stress and vascular function: implications for pharmacologic treatments,” Current Hypertension Reports, vol. 12, no. 3, pp. 154–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Spychalowicz, G. Wilk, T. Śliwa, D. Ludew, and T. J. Guzik, “Novel therapeutic approaches in limiting oxidative stress and inflammation,” Current Pharmaceutical Biotechnology, vol. 13, no. 13, pp. 2456–2466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kosuge and H. Kamiya, “Discovery of a pyrazine in a natural product: tetramethylpyrazine from cultures of a strain of bacillus subtilis,” Nature, vol. 193, no. 4817, p. 776, 1962. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Peng, D. Hucks, R. M. Priest, Y. M. Kan, and J. P. T. Ward, “Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism,” British Journal of Pharmacology, vol. 119, no. 5, pp. 1063–1071, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. R. Jiang and K. J. Chen, “Pharmacological roles of ligustrazine incardio-/cerebrovascular systems and its progress in researches of clinical application,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 33, no. 5, pp. 707–711, 2013. View at Google Scholar
  12. L. Lv, S.-S. Jiang, J. Xu, J.-B. Gong, and Y. Cheng, “Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 1, pp. 20–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Jiang, J. Qian, S. Chen, W. Zhang, and C. Liu, “Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress,” Pharmaceutical Biology, vol. 49, no. 8, pp. 856–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Shao, J. Li, Z. Zhao, C. Gao, Z. Sun, and X. Liu, “Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits,” Brain Research, vol. 1361, pp. 67–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Veal and A. Day, “Hydrogen peroxide as a signaling molecule,” Antioxidants and Redox Signaling, vol. 15, no. 1, pp. 147–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. M. Boulden, J. D. Widder, J. C. Allen et al., “Early determinants of H2O2-induced endothelial dysfunction,” Free Radical Biology and Medicine, vol. 41, no. 5, pp. 810–817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Cai, “Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences,” Cardiovascular Research, vol. 68, no. 1, pp. 26–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Wong, L. M. Yung, F. P. Leung et al., “Raloxifene protects endothelial cell function against oxidative stress,” British Journal of Pharmacology, vol. 155, no. 3, pp. 326–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kamper, O. Tsimpoukidi, A. Chatzigeorgiou, M. Lymberi, and E. F. Kamper, “The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats,” Translational Research, vol. 156, no. 1, pp. 26–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. G. W. Burton, A. Joyce, and K. U. Ingold, “First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma,” The Lancet, vol. 2, no. 8293, p. 327, 1982. View at Google Scholar · View at Scopus
  21. V. R. Muzykantov, “Targeting of superoxide dismutase and catalase to vascular endothelium,” Journal of Controlled Release, vol. 71, no. 1, pp. 1–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Petrônio, M. L. Zeraik, L. M. Da Fonseca, and V. F. Ximenes, “Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor,” Molecules, vol. 18, no. 3, pp. 2821–2839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Sebastian, A. Radermacher Kim, W. M. Kleikers Pamela, W. Kirstin, and H. H. W. Schmidt Harald, “Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement,” Antioxidants & Redox Signaling, 2014. View at Publisher · View at Google Scholar
  24. X. Y. Tian, L. H. Yung, W. T. Wong et al., “Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 237–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Dong, S. L. Wong, C. W. Lau et al., “Calcitriol restores renovascular function in estrogen-deficient rats through downregulation of cyclooxygenase-2 and the thromboxane-prostanoid receptor,” Kidney International, vol. 84, no. 1, pp. 54–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Li, S. Horke, and U. Förstermann, “Oxidative stress in vascular disease and itspharmacological prevention,” Trends in Pharmacological Sciences, vol. 34, no. 6, pp. 313–319, 2013. View at Google Scholar
  27. X. Gao, X.-L. Zhao, Y.-H. Zhu et al., “Tetramethylpyrazine protects palmitate-induced oxidative damage and mitochondrial dysfunction in C2C12 myotubes,” Life Sciences, vol. 88, no. 17-18, pp. 803–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Xu, P. Xia, X. Li, W. Wang, Z. Liu, and X. Gao, “Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis,” PLoS ONE, vol. 9, no. 2, Article ID e88243, 2014. View at Google Scholar
  29. H.-J. Wu, J. Hao, S.-Q. Wang, B.-L. Jin, and X.-B. Chen, “Protective effects of ligustrazine on TNF-α-induced endothelial dysfunction,” European Journal of Pharmacology, vol. 674, no. 2-3, pp. 365–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar
  31. B. Halliwell, M. V. Clement, and L. H. Long, “Hydrogen peroxide in the human body,” FEBS Letters, vol. 486, no. 1, pp. 10–13, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Fukai and M. Ushio-Fukai, “Superoxide dismutases: role in redox signaling, vascular function, and diseases,” Antioxidants and Redox Signaling, vol. 15, no. 6, pp. 1583–1606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Coyle, L. J. Martinez, M. C. Coleman, D. R. Spitz, N. L. Weintraub, and K. N. Kader, “Mechanisms of H2O2-induced oxidative stress in endothelial cells,” Free Radical Biology and Medicine, vol. 40, no. 12, pp. 2206–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Furchgott and P. M. Vanhoutte, “Endothelium-derived relaxing and contracting factors,” The FASEB Journal, vol. 3, no. 9, pp. 2007–2018, 1989. View at Google Scholar · View at Scopus
  35. A. Zembowicz, R. J. Hatchett, A. M. Jakubowski, and R. J. Gryglewski, “Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta,” British Journal of Pharmacology, vol. 110, no. 1, pp. 151–158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Cai, “NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease,” Circulation Research, vol. 96, no. 8, pp. 818–822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Schramm, P. Matusik, G. Osmenda, and T. J. Guzik, “Targeting NADPH oxidases in vascular pharmacology,” Vascular Pharmacology, vol. 56, no. 5-6, pp. 216–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Liao, C. C. Wu, and M. H. Yen, “Beneficial effects of tetramethylpyrazine, an active constituent of Chinese herbs, on rats with endotoxemia.,” Proceedings of the National Science Council, Republic of China. Part B, Life sciences, vol. 22, no. 1, pp. 46–54, 1998. View at Google Scholar · View at Scopus
  39. C.-C. Wu, M.-H. Liao, S.-J. Chen, and M.-H. Yen, “Tetramethylpyrazine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 360, no. 4, pp. 435–444, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. H. Yang, Y. Liang, Q. Xu, Y. Zhang, L. Xiao, and L. Y. Si, “Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes,” Phytomedicine, vol. 18, no. 13, pp. 1148–1152, 2011. View at Publisher · View at Google Scholar · View at Scopus